BJ
AMBI

BlackRock Japan’s Ambit Biosciences Corp AMBI Stock Holding History

BlackRock Japan’s Portfolio AMBI Stock Details AMBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,376
Closed -$30K – 1396
2014
Q2 		$30K Buy
4,376
+2,605
+147% +$18.3K ﹤0.01% 1111
2014
Q1 		$16K Buy
1,771
+1,459
+468% +$15.5K ﹤0.01% 1307
2013
Q4 		$3K Sell
312
-567
-65% -$7.57K ﹤0.01% 1326
2013
Q3 		$14K Buy
+879
New +$11.7K ﹤0.01% 1262

Other funds holding AMBI

FCMI
Foresite Capital Management I Larkspur, California $21.4M AUM 80.48% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

BlackRock Japan's AMBI Position: Q3 2014 in Review

BlackRock Japan sold out of Ambit Biosciences Corp (AMBI) in Q3 2014, closing a stake of 4,376 shares — an estimated $30K sold.

BlackRock Japan first reported a position in AMBI in Q3 2013 and held it in 4 quarters. The position peaked at $30K in Q2 2014. 49 funds tracked by Wall St. Rank hold AMBI as of Q3 2014.

  • BlackRock Japan reported no remaining Ambit Biosciences Corp position as of Q3 2014 after selling out during the quarter.
  • BlackRock Japan sold 4,376 Ambit Biosciences Corp shares in Q3 2014, an estimated $30K.
  • BlackRock Japan first reported a position in Ambit Biosciences Corp in Q3 2013 and held it in 4 quarters.
  • BlackRock Japan's Ambit Biosciences Corp position peaked at $30K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q3 2014.

Based on BlackRock Japan's 13F filing for Q3 2014, filed 29 Oct 2014.